Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
05/13/2009 | CN101432308A FAS binding antibodies |
05/13/2009 | CN101432307A Cytotoxicity mediation of cells evidencing surface expression of CD44 |
05/13/2009 | CN101432306A Methods and compositions for targeting RELT |
05/13/2009 | CN101432305A Transferrin receptor antibodies |
05/13/2009 | CN101432304A Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor |
05/13/2009 | CN101432303A Methods for damaging cells using effector functions of anti-CDH3 antibodies |
05/13/2009 | CN101432302A Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibod |
05/13/2009 | CN101432301A Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
05/13/2009 | CN101432023A Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies |
05/13/2009 | CN101432022A Methods for damaging cells using effector functions of anti-epha4 antibodies |
05/13/2009 | CN101432020A Methods and materials for the inhibition of transplant rejection |
05/13/2009 | CN101432018A IL-13 binding agents |
05/13/2009 | CN101429507A Heavy chain and light chain variable region gene of microcapsule algae toxin resistant monoclone antibody, and uses thereof |
05/13/2009 | CN101429250A Mold toxin penicillic acid monoclone antibody and preparation method thereof |
05/13/2009 | CN101429249A Anti-human chorionic gonadotrophin beta subunit monoclone antibody and preparation method thereof |
05/13/2009 | CN101429248A Anti-double-chain DNA monoclone antibody with antineoplastic activity and preparation method thereof |
05/13/2009 | CN101429247A Oriental schistosomiasis resistant natural numerator vaccine specific single-chain antibody |
05/13/2009 | CN101429246A Method for producing immunoglobulins containing protection proteins and their use |
05/13/2009 | CN101429244A Tetracycline and carrier protein couplet product, method for producing tetracycline antibiotic antibody uses thereof |
05/13/2009 | CN101429243A Melamine and carrier protein couplet product, preparation method and uses of melamine antibody |
05/13/2009 | CN101429242A Gentamicin and carrier protein couplet product, method for producing gentamicin antibody and uses thereof |
05/13/2009 | CN101429241A Penicillin and carrier protein couplet product, method for producing beta-lactam penicillin antibody, and uses thereof |
05/13/2009 | CN101429236A Type II non-structural protein 2B of dengue virus, recombinant expression vector, preparation and uses thereof |
05/13/2009 | CN100486996C Antibodies to human MCP-1 |
05/13/2009 | CN100486995C Compositions and methods for WT1 specific immunotherapy |
05/12/2009 | US7531896 Semiconductor device having a minimal via resistance created by applying a nitrogen plasma to a titanium via liner |
05/12/2009 | US7531648 Gene therapy |
05/12/2009 | US7531645 By ion exchange chromatography and involves changing the conductivity and/or pH of buffers in order to resolve the polypeptide of interest |
05/12/2009 | US7531643 Detection human integrin associated protein |
05/12/2009 | US7531642 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease |
05/12/2009 | US7531641 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) |
05/12/2009 | US7531640 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease |
05/12/2009 | US7531639 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) |
05/12/2009 | US7531638 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) |
05/12/2009 | US7531637 Produced by hybridomas; antipruritic agents; blocks scratching, dermatitis, or hairloss |
05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
05/12/2009 | US7531635 Monoclonal antibodies or functional fragment; immunoassay kit; female fertility diagnosis; Premature ovarian failure |
05/12/2009 | US7531634 Bladder matrix protein peptides and methods of detection of bladder cancer |
05/12/2009 | US7531633 Immunotherapy against infection; harvesting antibodies directed against Staphylococcus from blood of immunized subject for use as immunotherapeutic agents |
05/12/2009 | US7531628 Canine CD20 compositions |
05/12/2009 | US7531626 Tenebrio antifreeze proteins |
05/12/2009 | US7531522 Polynucleotide with a sequence coding for a fusion protein that is an anti-fungal protein or peptide and an antibody FV fragment specifically recognising an epitope of an Ascomyceta, and a cellular targeting signal |
05/12/2009 | US7531342 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
05/12/2009 | US7531322 Using tissue specific gene transfer element as tool in somatic gene therapy |
05/12/2009 | US7531314 to produce anti-peptide antibodies, then radiolabeling the antibody, administering the radiolabeled antibody to the patient, detecting and quantifying the binding of the radiolabeled antibody to determine the extent of neurofibrillary tangles and amyloid plaques in the patient |
05/12/2009 | US7531304 Method for screening FGFR-4 agonists |
05/12/2009 | US7531179 Bipolymer conjugate comprising botulin-a peptide for use in conferring tolerance to clostridial toxin |
05/12/2009 | US7531178 Immunoadhesin comprising a glycoprotein VI domain |
05/12/2009 | US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
05/12/2009 | US7531174 for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; genetic engineering; |
05/12/2009 | US7531171 Antibodies to non-functional P2X7 receptor |
05/12/2009 | US7531170 Administering an antibody that specifically binds to OX40 ligand (OX4L) sufficient to reduce or inhibit a recall immune response associated with or that causes asthma |
05/12/2009 | US7531169 or an antigen binding fragment comprising variable light chain region and heavy chain peptides, directed against isotypic determinants of immunoglobulin E (IgE), useful for diagnostics, prophylaxis and treatment of disease such as asthma, rhinitis, eczema, urticaria. dermatitis or food allergies |
05/12/2009 | US7531168 Method for downmodulating immune response in type I diabetes |
05/12/2009 | US7531166 IL-1β binding antibodies and fragments thereof |
05/12/2009 | CA2284079C Immunotoxins and methods of inducing immune tolerance |
05/12/2009 | CA2244195C Pin m iii gene in white pine |
05/12/2009 | CA2109977C Giardia vaccines |
05/07/2009 | WO2009058870A1 Compositions and methods for modulating immune responses |
05/07/2009 | WO2009058812A1 Antibody purification by cation exchange chromatography |
05/07/2009 | WO2009058797A1 Anti-hepcidin antibodies and uses thereof |
05/07/2009 | WO2009058769A1 Purification of antibodies containing hydrophobic variants |
05/07/2009 | WO2009058564A2 Immunosuppressive polypeptides and nucleic acids |
05/07/2009 | WO2009058492A2 Fc variants with altered binding to fcrn |
05/07/2009 | WO2009058346A1 Antibodies to gdf8 as uses thereof |
05/07/2009 | WO2009058203A1 Radiolabeled monoclonal antibodies, methods of preparation using tcep, and uses thereof |
05/07/2009 | WO2009057664A1 Antibody and use thereof |
05/07/2009 | WO2009057437A1 Method of creating wheat variety and wheat product |
05/07/2009 | WO2009056634A2 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6) |
05/07/2009 | WO2009056631A2 Molecules and methods for modulating complement component |
05/07/2009 | WO2009056584A1 Anticomplement polypeptides of ixodes ricinus |
05/07/2009 | WO2009056580A1 Rabbit monoclonal antibody (mab cv152) anti-indoleamine 2 3-dioxygenase (ido) |
05/07/2009 | WO2009056509A1 Improved nogo-a binding molecules and pharmaceutical use thereof |
05/07/2009 | WO2009056490A1 NEW ANTIBODIES SPECIFIC OF THE β-AMYLOID PEPTIDES AND THEIR USES AS DIAGNOSTIC AGENTS OR DRUGS |
05/07/2009 | WO2009056330A1 Soluble truncated apom proteins and medical uses thereof |
05/07/2009 | WO2009056280A1 Antibodies which bind selectively to hair of animals and an antibody based drug delivery system for animals |
05/07/2009 | WO2009056268A1 An antigen associated with rheumatoid arthritis |
05/07/2009 | WO2009055936A1 Humanized anti-venezuelan equine encephalitis virus recombinant antibodies |
05/07/2009 | WO2009036209A3 Homogeneous antibody populations |
05/07/2009 | WO2009035420A8 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
05/07/2009 | WO2009020645A3 Matriptase protein and uses thereof |
05/07/2009 | WO2009007993A4 A process for purification of immunoglobulins using a pseudobioaffinity adsorbent |
05/07/2009 | WO2008133873A3 Fgf-binding fusion proteins |
05/07/2009 | WO2008112543A3 Rat, rabbit, and cynomolgus monkey il-21 and il-22 nucleotide and polypeptide sequences |
05/07/2009 | WO2007061988A3 Methods for determining notch signaling and uses thereof |
05/07/2009 | WO2007061936A3 Clearance of abnormal iga1 in iga1 deposition diseases |
05/07/2009 | WO2007014162A3 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis |
05/07/2009 | WO2006132809A3 Monoclonal antibody reagents |
05/07/2009 | WO2006125202A3 Anti- mcp-1 antibodies, compositions, methods and uses |
05/07/2009 | WO2006029398A3 All-trans-retinol : all-trans-13,14-dihydroretinol saturase and methods of its use |
05/07/2009 | WO2005112999A3 Cancer treatment with inhibitors of collagen synthesis |
05/07/2009 | US20090118486 Uspa1 and uspa2 antigens of moraxella catarrhalis |
05/07/2009 | US20090118473 MN Gene and Protein |
05/07/2009 | US20090118472 Biomarkers for toxic algae |
05/07/2009 | US20090118219 Flea gaba receptor subunit nucleic acid molecules |
05/07/2009 | US20090118217 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
05/07/2009 | US20090118186 administering to a cancer patient a soluble tumor necrosis factor related apoptosis inducing ligand (TRAIL) polypeptide, selected from the extracellular domain of human TRAIL or fragment thereof, in the form of an oligomer; treatment of leukemia, melanoma or lymphoma |
05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
05/07/2009 | US20090118174 Novel peptides and methods for the treatment of inflammatory disorders |
05/07/2009 | US20090118141 Methods of oligosaccharide profiling for the detection of ocular rosacea |